KATHERINE SANDSTROM: Open Payments
NPI 1982973095 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 48 payments from 13 companies in 2025. Trend: 2023 $1,869 · 2024 $1,481 · 2025 $1,025
Food & beverage: $913Education: $112
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $365 |
| Janssen Biotech, Inc. | 17 | $282 |
| GENZYME CORPORATION | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| Lilly USA, LLC | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| LEO Pharma Inc. | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, COSENTYX, TALTZ, ANZUPGO, NEMLUVIO.
Industry payments across OR — which companies pay providers there.
